NYSE:VRX   VALEANT PHARMACEUTICALS INTERNATIONAL INC
New management has done an impressive job to turn around Valeant since Jan 2016. Under promised over delivered. Cash flow is strong and US$ index decline helps Valeant to improve its bottom line.

Technically the bottom pattern is almost finished and with a good ER in next month, I expect the rally continues.
Very interesting your point of view!
Reply
English
English (UK)
English (IN)
Deutsch
Français
Español
Italiano
Polski
Türkçe
Русский
Português
Bahasa Indonesia
Bahasa Melayu
ภาษาไทย
Tiếng Việt
日本語
한국어
简体中文
繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out